Literature DB >> 19383295

Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue.

P A Usher1, A M Sieuwerts, A Bartels, U Lademann, H J Nielsen, L Holten-Andersen, J A Foekens, N Brünner, H Offenberg.   

Abstract

TIMP-1 is a promising new candidate as a prognostic marker in colorectal and breast cancer. We now describe the discovery of two alternatively spliced variants of TIMP-1 mRNA. The two variants lacking exon 2 (del-2) and 5 (del-5), respectively, were identified in human cancer cell lines by RT-PCR. The del-2 variant was, furthermore, detected in extracts from 12 colorectal cancer tissue samples. By western blotting additional bands of lower molecular mass than full-length TIMP-1 were identified in tumor tissue, but not in plasma samples obtained from cancer patients. The two splice variants of TIMP-1 may hold important clinical information, and either alone or in combination with measurement of full-length TIMP-1 they may improve the prognostic and/or predictive value of TIMP-1 analyses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19383295      PMCID: PMC5543896          DOI: 10.1016/j.molonc.2007.05.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  37 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms.

Authors:  Takemi Akahane; Manabu Akahane; Amy Shah; Christine M Connor; Unnur P Thorgeirsson
Journal:  Exp Cell Res       Date:  2004-12-10       Impact factor: 3.905

3.  Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.

Authors:  T Hayakawa; K Yamashita; K Tanzawa; E Uchijima; K Iwata
Journal:  FEBS Lett       Date:  1992-02-17       Impact factor: 4.124

4.  Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer.

Authors:  Anne-Sofie Schrohl; Mads N Holten-Andersen; Harry A Peters; Maxine P Look; Marion E Meijer-van Gelder; Jan G M Klijn; Nils Brünner; John A Foekens
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

5.  In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

Authors:  L Guedez; W G Stetler-Stevenson; L Wolff; J Wang; P Fukushima; A Mansoor; M Stetler-Stevenson
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

6.  The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.

Authors:  G Murphy; A Houbrechts; M I Cockett; R A Williamson; M O'Shea; A J Docherty
Journal:  Biochemistry       Date:  1991-08-20       Impact factor: 3.162

7.  Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis.

Authors:  Lydia Nakopoulou; Ioanna Giannopoulou; Kalliopi Stefanaki; Effie Panayotopoulou; Ioanna Tsirmpa; Paraskevi Alexandrou; John Mavrommatis; Sophia Katsarou; Panagiotis Davaris
Journal:  J Pathol       Date:  2002-07       Impact factor: 7.996

8.  Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases).

Authors:  M K Bodden; G J Harber; B Birkedal-Hansen; L J Windsor; N C Caterina; J A Engler; H Birkedal-Hansen
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

9.  Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization.

Authors:  G P Stricklin; H G Welgus
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis.

Authors:  M L Davidsen; S Ø Würtz; M U Rømer; N M Sørensen; S K Johansen; I J Christensen; J K Larsen; H Offenberg; N Brünner; U Lademann
Journal:  Br J Cancer       Date:  2006-10-23       Impact factor: 7.640

View more
  7 in total

Review 1.  Association of TIMP-1 and COL4A4 Gene Polymorphisms with Keratoconus in an Iranian Population.

Authors:  Davood Yari; Zohreh Ehsanbakhsh; Mohammad-Hosein Validad; Farzaneh Hasanian Langroudi
Journal:  J Ophthalmic Vis Res       Date:  2020-08-06

2.  Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue.

Authors:  P A Usher; A M Sieuwerts; A Bartels; U Lademann; H J Nielsen; L Holten-Andersen; J A Foekens; N Brünner; H Offenberg
Journal:  Mol Oncol       Date:  2007-05-21       Impact factor: 6.603

3.  Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.

Authors:  Charlotte Aaberg-Jessen; Karina Christensen; Hanne Offenberg; Annette Bartels; Tanja Dreehsen; Steinbjørn Hansen; Henrik Daa Schrøder; Nils Brünner; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

4.  TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.

Authors:  Marion Flodrops; Gwendal Dujardin; Adeline Busson; Pascal Trouvé; Chandran Ka; Brigitte Simon; Danielle Arzur; Catherine Le Jossic-Corcos; Laurent Corcos
Journal:  Mol Biol Rep       Date:  2020-03-21       Impact factor: 2.316

5.  JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.

Authors:  Xujun Liu; Wenzhe Si; Xinhua Liu; Lin He; Jie Ren; Ziran Yang; Jianguo Yang; Wanjin Li; Shumeng Liu; Fei Pei; Xiaohan Yang; Luyang Sun
Journal:  Mol Cancer       Date:  2017-11-29       Impact factor: 27.401

6.  Transcriptomic Analysis of Gene Networks Regulated by U11 Small Nuclear RNA in Bladder Cancer.

Authors:  Zhenxing Wang; Xi Wang; Yaobang Wang; Shaomei Tang; Chao Feng; Lixin Pan; Qinchen Lu; Yuting Tao; Yuanliang Xie; Qiuyan Wang; Zhong Tang
Journal:  Front Genet       Date:  2021-07-02       Impact factor: 4.599

Review 7.  Alternative splicing for diseases, cancers, drugs, and databases.

Authors:  Jen-Yang Tang; Jin-Ching Lee; Ming-Feng Hou; Chun-Lin Wang; Chien-Chi Chen; Hurng-Wern Huang; Hsueh-Wei Chang
Journal:  ScientificWorldJournal       Date:  2013-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.